IL-15激活的旁观者CD8+肿瘤浸润T细胞参与非小细胞肺癌肿瘤控制
该研究分析66例非小细胞肺癌组织中的旁观者CD8+肿瘤浸润T细胞,发现多种病毒特异性旁观者CD8+ T细胞存在于人NSCLC组织中。体外IL-15刺激可上调CD8+ TIL的NKG2D表达并导致NKG2D依赖性IFN-γ产生(p=0.0006)。在小鼠NSCLC模型中,IL-15治疗仅在MCMV感染小鼠中减少肺部肿瘤结节数(p=0.0037),提示旁观者CD8+ TIL可被IL-15重定向用于肿瘤免疫治疗。
要点
- 人NSCLC组织中存在多种病毒特异性旁观者CD8+ TIL
- IL-15体外刺激上调CD8+ TIL的NKG2D并促进IFN-γ产生
- IL-15仅在MCMV感染小鼠中减少肺部肿瘤结节
核心结论
- 旁观者CD8+ TIL可被IL-15重定向用于肿瘤免疫治疗。
研究设计与样本
- 研究分析非小细胞肺癌组织(N=66)中旁观者CD8+ TIL的特征及其IL-15激活。
- 采用小鼠NSCLC模型,比较有或无MCMV感染史时IL-15治疗对肿瘤生长的影响。
主要发现
- 多种病毒特异性旁观者CD8+ TIL存在于人NSCLC组织中。
- IL-15处理上调CD8+ TIL的NKG2D表达,导致NKG2D依赖性IFN-γ产生(p=0.0006)。
- IL-15治疗仅在MCMV感染小鼠中减少肺部肿瘤结节数(p=0.0037)。
- MCMV特异性旁观者CD8+ TIL在IL-15治疗后产生IFN-γ。
- MCMV感染小鼠IL-15治疗上调肿瘤微环境中TNF-α和IFN-γ应答基因。
临床怎么用
- 提示IL-15可能作为重定向旁观者CD8+ TIL的抗肿瘤免疫治疗策略。
- 疗效可能依赖体内病毒特异性旁观者T细胞的存在。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tumour-unrelated, virus-specific bystander CD8+ T cells were recently shown to be abundant among tumour-infiltrating lymphocytes (TILs). However, their roles in tumour immunity have not been elucidated yet. METHODS: We studied the characteristics of bystander CD8+ TILs from non-small cell lung cancer (NSCLC) tissues (N=66) and their activation by interleukin (IL)-15 to repurpose them for tumour immunotherapy. RESULTS: We show that bystander CD8+ TILs specific to various viruses are present in human NSCLC tissues. We stimulated CD8+ TILs ex vivo using IL-15 without cognate antigens and found that IL-15 treatment upregulated NKG2D expression on CD8+ TILs, resulting in NKG2D-dependent production of interferon (IFN)-γ (p=0.0006). Finally, we tested whether IL-15 treatment can control tumour growth in a murine NSCLC model with or without a history of murine cytomegalovirus (MCMV) infection. IL-15 treatment reduced the number of tumour nodules in the lung only in mice with MCMV infection (p=0.0037). We confirmed that MCMV-specific bystander CD8+ TILs produced interferon (IFN)-γ after IL-15 treatment, and that IL-15 treatment in MCMV-infected mice upregulated tumour necrosis factor-α and IFN-γ responsive genes in tumour microenvironment. CONCLUSION: Thus, the study demonstrates that bystander CD8+ TILs can be repurposed by IL-15 for tumour immunotherapy.
引用
- Leem G, Jeon M, Kim KW, et al. Tumour-infiltrating bystander CD8+ T cells activated by IL-15 contribute to tumour control in non-small cell lung cancer. Thorax. 2021. PMID: 34853159. doi:10.1136/thoraxjnl-2021-217001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。